Addressing Transgender Erasure in HIV Clinical Trials
The scorecard for transgender and gender-diverse inclusion
Scorecard indicators reveal a dearth of HIV research responsive to the needs of transgender and gender-diverse (TGD) communities. The lack of TGD representation in HIV clinical trials indicates a historical erasure of TGD communities with potential public health consequences. The scorecard might guide future HIV research to be more responsive to the needs of TGD people. Published in the American Journal of Public Health.
Was this content helpful?
Tell us how we can improve the content.
Was this content helpful?
Thank you for your feedback!